Identification and validation of STEAP3 as a ferroptosis-related biomarker in heart failure - Summary - MDSpire

Identification and validation of STEAP3 as a ferroptosis-related biomarker in heart failure

  • By

  • Huijuan Chen

  • Lingqi Xu

  • June 1, 2026

  • 0 min

Share

Objective:

To identify specific aging-related programmed cell death (PCD) signatures in heart failure (HF) and explore their potential as biomarkers.

Key Findings:
  • Ferroptosis, autophagy, and necroptosis were strongly correlated with aging in HF.
  • Eighteen differentially expressed aging-related PCD genes were identified.
  • The LASSO model demonstrated the best diagnostic performance.
  • Significant differences in the immune microenvironment were observed between high and low aging-PCD index groups.
  • A regulatory network of 15 key genes and 19 transcription factors was constructed.
  • STEAP3 may participate in ferroptosis-related injury in cardiomyocytes through glutathione metabolism and iron homeostasis.
Interpretation:

The study identifies aging-related PCD signatures in HF, suggesting potential biomarkers for clinical validation.

Limitations:
  • The study was limited to a small sample size of 22 participants, which may affect the generalizability of the findings.
  • The training and validation datasets were analyzed independently without batch effect correction.
Conclusion:

Aging-related PCD signatures in HF may provide candidate biomarkers for further clinical validation.

Original Source(s)

Related Content